Literature DB >> 24703486

Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration.

Janice J Hwang1, Bindiya Thakkar2, John P Chamberland3, Christos S Mantzoros4.   

Abstract

OBJECTIVE: Fetuin-A may mediate cross-talk between the liver and adipose tissue. We studied the physiologic regulation of fetuin-A and explored its potential regulation by leptin. DESIGN AND METHODS: Fetuin-A levels were measured in three interventional studies as well as in in vitro experiments. Study 1: 15 lean subjects received placebo or physiologic replacement-dose recombinant human leptin (metreleptin) following short term complete caloric deprivation to induce severe hypoleptinemia; Study 2: 7 women with relative leptin deficiency due to strenuous exercise or low weight received 3 months of metreleptin; Study 3: 17 women with relative leptin deficiency were randomized to receive metreleptin or placebo over 9 months. In study 4 human hepatoma Hep G2 cells were treated with leptin. Fetuin-A mRNA expression and secretion were measured.
RESULTS: Complete caloric deprivation significantly decreased leptin but had no effect on fetuin-A levels. Normalizing leptin levels with metreleptin in hypoleptinemic subjects had no effect on circulating fetuin-A levels. Leptin treatment had no effect on fetuin-A mRNA expression and secretion in vitro.
CONCLUSIONS: Circulating fetuin-A levels are not affected by short and long-term energy deprivation. Furthermore, both in vivo and in vitro experiments confirm that fetuin-A is not regulated by leptin. Published by Elsevier Inc.

Entities:  

Keywords:  Alpha-2-Heremans-Schmid glycoprotein; Fetuin-A; Leptin

Mesh:

Substances:

Year:  2014        PMID: 24703486      PMCID: PMC5501325          DOI: 10.1016/j.metabol.2014.02.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  29 in total

1.  Association of fetuin-A level and diabetes risk.

Authors:  Norbert Stefan; Hans-Ulrich Häring; Matthias B Schulze
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

2.  Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl.

Authors:  J von Schnurbein; M Heni; A Moss; S A Nagel; J Machann; H Muehleder; K M Debatin; S Farooqi; M Wabitsch
Journal:  Horm Res Paediatr       Date:  2013-05-07       Impact factor: 2.852

3.  Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

Authors:  Elizabeth Sienkiewicz; Faidon Magkos; Konstantinos N Aronis; Mary Brinkoetter; John P Chamberland; Sharon Chou; Kalliopi M Arampatzi; Chuanyun Gao; Anastasia Koniaris; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-07-07       Impact factor: 8.694

4.  Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

Authors:  Alisan Kahraman; Jan-Peter Sowa; Martin Schlattjan; Svenja Sydor; Martin Pronadl; Alexander Wree; Anja Beilfuss; Alpaslan Kilicarslan; Akif Altinbaş; Lars Peter Bechmann; Wing-Kin Syn; Guido Gerken; Ali Canbay
Journal:  Clin Sci (Lond)       Date:  2013-10       Impact factor: 6.124

5.  Leptin is an effective treatment for hypothalamic amenorrhea.

Authors:  Sharon H Chou; John P Chamberland; Xiaowen Liu; Giuseppe Matarese; Chuanyun Gao; Rianna Stefanakis; Mary T Brinkoetter; Huizhi Gong; Kalliopi Arampatzi; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

6.  The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial.

Authors:  Kyung Mook Choi; Kyung Ah Han; Hee Jung Ahn; So Young Lee; Soon Young Hwang; Baek-Hui Kim; Ho Cheol Hong; Hae Yoon Choi; Sae Jeong Yang; Hye Jin Yoo; Sei Hyun Baik; Dong Seop Choi; Kyung Wan Min
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-06       Impact factor: 3.478

7.  Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

8.  Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake.

Authors:  K K Miller; M S Parulekar; E Schoenfeld; E Anderson; J Hubbard; A Klibanski; S K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

9.  Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans.

Authors:  Janice J Hwang; Jean L Chan; Georgia Ntali; Dalia Malkova; Christos S Mantzoros
Journal:  Diabetes Care       Date:  2008-02-05       Impact factor: 19.112

10.  Plasma fetuin-A levels and the risk of type 2 diabetes.

Authors:  Norbert Stefan; Andreas Fritsche; Cornelia Weikert; Heiner Boeing; Hans-Georg Joost; Hans-Ulrich Häring; Matthias B Schulze
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

View more
  4 in total

1.  New research developments and insights from Metabolism.

Authors:  Olivia M Farr; Michelle Camp; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-12-17       Impact factor: 8.694

2.  Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren.

Authors:  Giuseppe Murdolo; Cristina Tortoioli; Federica Celi; Vittorio Bini; Francesco Papi; Annalisa Brozzetti; Alberto Falorni
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

3.  Dynamic Changes of Heart Failure Biomarkers in Response to Parabolic Flight.

Authors:  Peter Jirak; Bernhard Wernly; Michael Lichtenauer; Vera Paar; Marcus Franz; Thorben Knost; Thaer Abusamrah; Malte Kelm; Johanna M Muessig; Nana-Yaw Bimpong-Buta; Christian Jung
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

Review 4.  Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD.

Authors:  Ojus Sardana; Ravi Goyal; Onkar Bedi
Journal:  Inflammopharmacology       Date:  2021-06-29       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.